Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jun 30, 2020 |
Director
Trans History: 14
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
Jun 30, 2020 |
Director
Trans History: 14
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
Jun 30, 2020 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
Jun 30, 2020 |
Director
Trans History: 8
|
Director | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,470 | -- | 44,470 |
May 12, 2023 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,496 | $0.66 | 297,842 |
May 12, 2022 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 41,496 | $1.41 | 216,669 |
Aug 17, 2021 |
Director
Trans History: 18
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
Aug 17, 2021 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
Aug 17, 2021 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
Aug 17, 2021 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.